These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10093870)

  • 1. Correlates of insight and insight change in schizophrenia.
    Carroll A; Fattah S; Clyde Z; Coffey I; Owens DG; Johnstone EC
    Schizophr Res; 1999 Feb; 35(3):247-53. PubMed ID: 10093870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling interrelationships among psychopathology symptoms, cognitive domains and insight dimensions in chronic schizophrenia.
    Xavier RM; Pan W; Dungan JR; Keefe RSE; Vorderstrasse A
    Schizophr Res; 2018 Mar; 193():83-90. PubMed ID: 28693755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of early premorbid adjustment with negative symptoms and cognitive functions in first-episode schizophrenia: a prospective three-year follow-up study.
    Chang WC; Tang JY; Hui CL; Wong GH; Chan SK; Lee EH; Chen EY
    Psychiatry Res; 2013 Oct; 209(3):353-60. PubMed ID: 23473654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological correlates of cognitive insight in schizophrenia.
    Orfei MD; Spoletini I; Banfi G; Caltagirone C; Spalletta G
    Psychiatry Res; 2010 Jun; 178(1):51-6. PubMed ID: 20452049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
    Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
    J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(4):267-72. PubMed ID: 9417392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The course of depressive symptoms in predicting relapse in schizophrenia: a double-blind, randomized comparison of olanzapine and risperidone.
    Tollefson GD; Andersen SW; Tran PV
    Biol Psychiatry; 1999 Aug; 46(3):365-73. PubMed ID: 10435202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care.
    Vita A; Deste G; Barlati S; De Peri L; Giambra A; Poli R; Keefe RS; Sacchetti E
    Schizophr Res; 2013 May; 146(1-3):217-23. PubMed ID: 23510596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships of age at onset with clinical features and cognitive functions in a sample of schizophrenia patients.
    Bellino S; Rocca P; Patria L; Marchiaro L; Rasetti R; Di Lorenzo R; Paradiso E; Bogetto F
    J Clin Psychiatry; 2004 Jul; 65(7):908-14. PubMed ID: 15291678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates, change and 'state or trait' properties of insight in schizophrenia.
    Wiffen BD; Rabinowitz J; Lex A; David AS
    Schizophr Res; 2010 Sep; 122(1-3):94-103. PubMed ID: 20382507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of insight with psychotic symptoms, depression, and cognition in early psychosis: a 3-year follow-up.
    Saeedi H; Addington J; Addington D
    Schizophr Res; 2007 Jan; 89(1-3):123-8. PubMed ID: 17097272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of depression with cognitive insight and socio-occupational outcome in patients with schizophrenia.
    Grover S; Sahoo S; Nehra R; Chakrabarti S; Avasthi A
    Int J Soc Psychiatry; 2017 May; 63(3):181-194. PubMed ID: 28162014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The five symptom dimensions and depression in schizophrenia.
    Lee KH; Harris AW; Loughland CM; Williams LM
    Psychopathology; 2003; 36(5):226-33. PubMed ID: 14571051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight in inpatients with schizophrenia: relationship to symptoms and neuropsychological functioning.
    Zhou Y; Rosenheck R; Mohamed S; Zhang J; Chang Q; Ou Y; Sun B; Ning Y; He H
    Schizophr Res; 2015 Feb; 161(2-3):376-81. PubMed ID: 25533592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia.
    Addington J; Addington D
    J Psychiatry Neurosci; 1993 Jan; 18(1):18-23. PubMed ID: 8461276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A structural equation modelling approach to explore the determinants of quality of life in schizophrenia.
    Alessandrini M; Lançon C; Fond G; Faget-Agius C; Richieri R; Faugere M; Metairie E; Boucekine M; Llorca PM; Auquier P; Boyer L
    Schizophr Res; 2016 Mar; 171(1-3):27-34. PubMed ID: 26781001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insight and symptom change in schizophrenia and other disorders.
    Weiler MA; Fleisher MH; McArthur-Campbell D
    Schizophr Res; 2000 Sep; 45(1-2):29-36. PubMed ID: 10978870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight: its relationship with cognitive function, brain volume and symptoms in schizophrenia.
    Rossell SL; Coakes J; Shapleske J; Woodruff PW; David AS
    Psychol Med; 2003 Jan; 33(1):111-9. PubMed ID: 12537042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between cognitive insight, clinical insight, and depression in patients with schizophrenia.
    Ekinci O; Ugurlu GK; Albayrak Y; Arslan M; Caykoylu A
    Compr Psychiatry; 2012 Feb; 53(2):195-200. PubMed ID: 21489416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal prediction error is associated with negative and depressive symptoms in schizophrenia.
    Moran PM; Owen L; Crookes AE; Al-Uzri MM; Reveley MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):116-23. PubMed ID: 17764799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.